Accent Assays Inc is a molecular diagnostics and healthcare company that has developed a blood test, HDL Nexus, measuring the functional capacity of plasma high-density lipoprotein (HDL), the "good" cholesterol. Two hundred and fifty million cholesterol assays are preformed in the United States, with another five hundred million more done worldwide, resulting in a market value of $4B and $8B annually. This market is expected to grow with pressure from the healthcare industry and an emphasis by both policy makers and for-profit insurers to develop preventive measures and improve lifestyle and the effectiveness of pharmacological interventions.